Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer
This study has been completed.
Sponsor:
CMX Research
Collaborator:
Sanofi
Information provided by (Responsible Party):
CMX Research
ClinicalTrials.gov Identifier:
NCT00426777
First received: January 24, 2007
Last updated: February 2, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2009 |
| Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |